DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kantarjian H, Thomas D, Jorgensen J. et al.
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia.
Cancer 2013;
119 (15) 2728-2736
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.